A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life
A Decentralized, Double-blinded, Randomized, 18 Month, Parallel-group, Superiority Study to Evaluate the Impact of Complement Theory's Live Coactive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life
1 other identifier
interventional
146
1 country
1
Brief Summary
A Decentralized, Double-blinded, Randomized, 18 month, Parallel-group, Superiority Study to evaluate the impact of Complement Theory's Live Coactive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2024
CompletedFirst Posted
Study publicly available on registry
May 3, 2024
CompletedStudy Start
First participant enrolled
May 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedDecember 17, 2025
December 1, 2025
1.8 years
April 25, 2024
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Impact of the program cancer survivors' Quality of Life Scores (QoLS), measured by the FACT-G instrument.
To quantify the impact of Complement Theory's Program on cancer survivors' Quality of Life, as measured by the change in FACT-G scores over the course of the trial.
18 months
Secondary Outcomes (2)
Effect on Employee Absenteeism
18 Months
Impact on Employee Presenteeism
18 Months
Study Arms (2)
Test Group
EXPERIMENTALLive CoActive Coaching program, focusing on Exercise and Meditation, along with evidence-based information on Diet, for 18 months
Control Group
ACTIVE COMPARATOR18 months access to Digital application with expert guidelines on lifestyle modification focusing on exercise, meditation, as well as information on diet, sleep and other lifestyle practices. Does not include live coaching and personalization.
Interventions
Participants will get access for 18 months to Complement Theory's Live CoActive Coaching program, focusing on Exercise and Meditation and supplemented with evidence-based information on Diet, adjunct to the core treatment. * Each week, up to five sessions of 45 minutes each will be offered, with a recommendation for participants to engage in a minimum of three sessions to ensure adequate program exposure and benefits. * Each session will consist of 30 Minutes of Physical Exercise and 7 minutes of meditation. Each session will be a combination session focused on Aerobic and Strength, with flexibility and balance exercises included as supplements.
18 months access to Digital application with expert guidelines on lifestyle modification focusing on exercise, meditation, as well as information on diet, sleep and other lifestyle practices.
Eligibility Criteria
You may qualify if:
- Cancer Type: Breast, Prostate, Colorectal, Lung and Other Cancer
- Cancer Stage: Stage 1 to 4
- Treatment Status: Has undergone any cancer-related treatment in last 12 months
- Age: Above 21 years
- Permission to access to last 1 year digital health records
- Access to smartphone or a tablet
You may not qualify if:
- Excludes individuals who have undergone surgery within the last 4 weeks or will undergo surgery in the next 4 weeks
- Participants declared medically unfit by their physicians to do physical exercise
- ECOG Score 3,4 or 5
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Complement Theory Inc.
Dover, Delaware, 19901, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudio L. Battaglini, PhD
University of North Carolina
- PRINCIPAL INVESTIGATOR
Erik Hanson, PhD
University of North Carolina
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2024
First Posted
May 3, 2024
Study Start
May 12, 2024
Primary Completion
February 28, 2026
Study Completion
February 28, 2026
Last Updated
December 17, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be available 3 months after the end trial and will be available for 2 years after the date of availability.
- Access Criteria
- Anyone shall be able access after following a simple data request process. The person has to detail the purpose and expected outcomes, which will be reviewed and approved by the Principal Investigators. Plus, we will also ensure appropriate documentation. We will employ a data use agreement to prohibit re-identification attempts and ensure data is used as per the agreed proposal. The overall process has been designed to make the data access as open as possible and as closed as necessary, to protect participant privacy and reduce the risk of data misuse.
De-identified data shall be shared. This includes both primary and secondary outcomes related data points.